跳至主要内容
临床试验/EUCTR2014-001012-19-NL
EUCTR2014-001012-19-NL进行中(未招募)不适用

Effects of fingolimod on functional brain adaptation and clinical measures in multiple sclerosis - Effect of fingolimod on brain and cognition

VU University Medical Center0 个研究点开始时间: 2014年10月15日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Subjects should be between 18 and 65 years of age
  • - Subjects should meet the safety criteria to undergo MRI examination
  • - Patients should be diagnosed with RRMS
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 70
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Presence or history of psychiatric or neurological disease (for patients: neurological disease other than MS)
  • - Presence or history of drug abuse
  • - For patients: relapse or steroid treatment less than four weeks prior to examination
  • - Insufficient visual acuity and motor skills to perform the fMRI task

研究者

发起方
VU University Medical Center

相似试验